Infective panniculitis

Author: Dr Tom Moodie, Dermatology Registrar, Waikato Hospital, Hamilton, New Zealand, 2013.

What is infective panniculitis?

Panniculitis is inflammation within the subcutaneous tissue. It has a variety of causes. An infective cause is more likely in those with immunodeficiency (a weakened immune system).

Immunodeficiency may be due to disease, such as infection with human immunodeficiency virus (HIV), or with the use of immune suppressive drugs (e.g. prescribed after organ transplantation). Immunodeficiency may lead to infection with unusual organisms and in unusual sites, including subcutaneous fat.

How does infective panniculitis present?

Infective panniculitis in general has no specific features. The clinical presentation depends on:

Infective panniculitis 
Staphylococcus
Infective panniculitis 
Atypical mycobacterium
Infective panniculitis 
Cause unknown
Infective panniculitis

How is the diagnosis of infective panniculitis made?

Whilst history is important, the diagnosis usually requires microbiological and histological confirmation. On biopsy, most infectious panniculitis causes a lobular pattern of inflammation. A lobular pattern is nonspecific although there are sometimes clues that an organism is responsible. Cultures and special stains are required to distinguish these.

Bacterial causes of panniculitis

Common bacteria that cause panniculitis include:

Bacterial panniculitis can appear in immunocompetent as well as immunosuppressed individuals. It can develop as a result of direct inoculation or from seeding from systemic infection.

The classical histopathological appearance is a lobular or mixed lobular/septal suppurative panniculitis with heavy infiltrate of neutrophils.

The choice of antibiotic depends on the bacteria. If the organism is unknown, broad spectrum antibiotic such as amoxicillin-clavulanic acid is often chosen.

Mycobacterial panniculitis

Mycobacteria have a wide range of skin manifestations and panniculitis is uncommon. Most mycobacterial panniculitis is due to non-tuberculous or atypical mycobacteria. They include:

Mycobacterial panniculitis is more frequently seen in immunocompromised individuals. It is usually the result of spread through the blood stream, which results in widespread lesions. Trauma is the usual means of inoculation in individuals with a normal immune system and results in a single lesion.

Histology demonstrates a lobular panniculitis, sometimes with granuloma formation. Zeihl-Nelson, aur-amine-rhodaine or Fite-Faraco stains are specialised mycobacterial stains that help highlight the organism. Cultures are more sensitive and allow for accurate identification of the mycobacterial species but can take many weeks. DNA probes and DNA PCR are quick ways of species identification.

Treatment regimes are specific to the species of mycobacterium. Treatment is usually continued for 6-12 months or at least 6-8 weeks after clinical resolution.

Treatment of cutaneous non-tuberculous mycobacterial infection
Micro organismFirst LineOther considerations
M chelonae Clarithromycin + ciprofloxacin/doxycycline Surgical debridement
Dual antimicrobial therapy
M fortuitum Amikacin + ciprofloxacin/doxycycline Surgical debridement
Dual antimicrobial therapy
M absessus Clarithromycin + amikacin/cefoxitin Surgical debridement/excision
M marinum Ethambutol + rifampicin or doxycycline Surgical debridement
M avium-intracellulare Ethambutol + clarithromycin + rifampicin Surgical excision

Fungal panniculitis

Fungal panniculitis can be separated into disseminated disease or classical subcutaneous mycosis.

Biopsyfungal culture and specific stains (silver impregnated procedure and periodic acid-Schiff) are required to make the diagnosis.

Treatment of fungal panniculitis depends on the identification of the organism.

Features of deep fungal infections
Disseminated fungal diseaseClassical subcutaneous mycosis
Causative organisms Candida spp, Aspergillus spp, Fusarium,Histoplasma. Sporotrichosis (Sporothrix schenckii), eumycetoma (Madurella mycetomatis), chromoblastomycosis (Phialophora verrocossa, Fonsecaea pedrosi and F compacta).
Patient characteristics Immunosuppressed individuals Healthy individual directly inoculated (soil, plant or wood)
Clinical manifestations Multiple inflammatory subcutaneous lesions
Individual very unwell
Single slowly growing subcutaneous nodule 
Can discharge pus and invade deep tissues
Histology Lobular panniculitis without vasculitis Lobular panniculitis without vasculitis
Occasionally, suppurative granuloma
Management Common therapy includes itraconazole or amphotericin B (for months) 
Surgical excision maybe needed for some lesions
Eumycetoma needs wide excision and ketoconazole (months) 
Chromoblastomycosis and Sporotrichosis are treated with itraconazole or terbinafine (months).

Viral panniculitis

The medical literature about viral panniculitis is limited to a few case reports. Cytomegalovirus (CMV) has been reported to cause panniculitis in an immunocommpromised patient.

 

Related information

Make a donation

Donate Today

Help us to update and maintain DermNet New Zealand

The History Of DermNet

Watch Dr Amanda Oakley presenting 'The History Of DermNet NZ' at The International Society Of Teledermatology.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter